Compositions And Methods For Generating An Immune Response
US Application 60/186,364
Filed on 2000-03-02
Filed on 2000-03-02
Chondroitin Sulphate A Binding Domains
US Application 60/615,300
Filed on 2004-09-30
Filed on 2004-09-30
Glycine As A Protein Stablzer In Montanide ISA 720 Vaccine Formulation
US Application 60/576,361
Filed on 2004-06-01
Filed on 2004-06-01
Isolation And Characterization Of Chimpanzee Monoclonal Antibodies Capable Of Efficiently Neutralizing Dengue Type 1,2,3 And 4 Viruses
US Application 60/541,676
Filed on 2004-02-04
Filed on 2004-02-04
HIV Vaccine Immunogens And Immunization Strategies To Elicit Broadly Neutralizing Anti-HIV-1 Against The Membrane-Proximal Ectodomain Of HIV Gp41
US Application 60/570,883
Filed on 2004-05-14
Filed on 2004-05-14
Safer Attenuated Virus Vaccines With Missing or Diminished Latency of Infection
US Application 60/583,399
Filed on 2004-06-29
Filed on 2004-06-29
Method of Using Adenoviral Vectors to Induce an Immune Response
US Application 60/561,341
Filed on 2004-04-12
Filed on 2004-04-12
Chimpaneze Monoclonal Antibodies That Neutralizes Vaccinia Virus (and Possibly Othe Pox Viruses)
US Application 60/753,437
Filed on 2005-12-22
Filed on 2005-12-22
Chimpaneze Monoclonal Antibody That Neutralizes Anthrax Protective Antigen (PA) Toxin
US Application 60/639,074
Filed on 2004-12-22
Filed on 2004-12-22
SARS Coronavirus MVA Vaccines And Therapy
US Application 60/558,995
Filed on 2004-04-05
Filed on 2004-04-05